We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

TRP:NYSETC Energy Corporation Analysis

Data as of 2026-03-11 - not real-time

$63.14

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Technical outlook: The short‑term moving average sits comfortably above the mid‑term average, which in turn leads the long‑term average, signaling a bullish backdrop. Momentum indicators are mixed – the RSI hovers in a neutral zone while the MACD histogram has turned negative, hinting at a potential short‑term pullback. Price is trading near a well‑tested support level with resistance ahead, and trading volume remains steady, reinforcing the current trend. The stock’s beta is low, suggesting limited market‑wide volatility, though recent price swings have been moderately high, and market sentiment is tilted toward extreme greed.
Fundamental backdrop: Revenue growth remains robust and margins are strong, but the balance sheet is heavily leveraged and free cash flow is negative, raising concerns about cash generation. The dividend yield is attractive, yet the payout ratio is near the top of the feasible range, questioning sustainability. A recent earnings beat and a 26th consecutive dividend increase have been offset by an analyst downgrade to neutral and a fair‑value estimate that sits below the current market price, indicating the stock may be overvalued at present.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bullish moving‑average alignment
  • Stable trading volume and support level
  • Mixed momentum signals and overvalued pricing

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Strong revenue growth and margins
  • High leverage and negative free cash flow
  • Attractive dividend but sustainability concerns

Long Term

> 3 years
Cautious
Model confidence: 4/10

Key Factors

  • Elevated debt load relative to equity
  • Dividend payout near 100% of earnings
  • Fair‑value estimate below current market price

Key Metrics & Analysis

Financial Health

Revenue Growth16.50%
Profit Margin23.09%
P/E Ratio24.8
ROE11.44%
ROA3.57%
Debt/Equity165.37
P/B Ratio3.6
Op. Cash Flow$7.3B
Free Cash Flow$-1839124992
Industry P/E21.9

Technical Analysis

TrendBullish
RSI57.8
Support$60.00
Resistance$65.57
MA 20$63.18
MA 50$59.10
MA 200$53.25
MACDBearish
VolumeStable
Fear & Greed Index78.16

Valuation

Fair Value$77.58
Target Price$57.50
Upside/Downside-8.93%
GradeOvervalued
TypeBlend
Dividend Yield4.06%

Risk Assessment

Beta0.29
Volatility18.93%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.